Skip to Content

  • Search

View Additional Section Content

A Phase III Randomized, Double-Blind, Placebo-Controlled, Parallel-Group, Multicenter, Efficacy and Safety Study of Gantenerumab in Patients with Mild Alzheimer's Disease.

For more information on this trial, click the link below.

https://clinicaltrials.gov/ct2/show/NCT02051608?term=nct02051608&rank=1

Clinical Trial Categories

  • Alzheimer's Disease
Contact
Jennifer McGowan at 215-327-0161

Location

  • Abington Neurological Associates, Ltd

Find a Physician
Search Our Directory

215-481-MEDI

Schedule a
Test

215-481-EXAM

Clinical Trials Details